Biotech · Private company
Genzyme, a Sanofi Company
Track this companyFree. Adds Genzyme, a Sanofi Company to your Dealase workspace and tells you when its record changes.
Clinical trials2518 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- FitusiranPhase 3 · HemophiliaClinicalTrials.gov · fetched Nov 12, 2026
- venglustat GZ402671Phase 3 · Tay-Sachs DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Alglucosidase alfa (GZ419829)Phase 2 · Glycogen Storage Disease Type II-Pompe's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Avalglucosidase alfa (GZ402666)Phase 2 · Glycogen Storage Disease Type II-Pompe's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- imiglucerasePhase 2 · Gaucher Disease Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- venglustat (GZ402671)Phase 2 · Gaucher Disease Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Alemtuzumab (GZ402673)Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)RECRUITING · started Sep 21, 2026ClinicalTrials.gov NCT07582276 · fetched Nov 12, 2026
- Glucose Consumption in MS Using [F-18]FDG-PETPHASE4 · RECRUITING · started May 31, 2025ClinicalTrials.gov NCT07087106 · fetched Nov 12, 2026
- Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal MelanomaPHASE2 · RECRUITING · started Nov 4, 2024ClinicalTrials.gov NCT06121180 · fetched Nov 12, 2026
- Isa-Pom-Dex in Elderly/Frail Subjects With RRMMPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 5, 2023ClinicalTrials.gov NCT05911321 · fetched Nov 12, 2026
- Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 31, 2023ClinicalTrials.gov NCT05346809 · fetched Nov 12, 2026
- Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple MyelomaPHASE2 · RECRUITING · started Feb 18, 2022ClinicalTrials.gov NCT05145400 · fetched Nov 12, 2026
- Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 29, 2021ClinicalTrials.gov NCT04883242 · fetched Nov 12, 2026
- Isatuximab in Patients With Monoclonal Gammopathy of Renal SignificancePHASE2 · ACTIVE_NOT_RECRUITING · started Jun 8, 2021ClinicalTrials.gov NCT04614558 · fetched Nov 12, 2026
- ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramENROLLING_BY_INVITATION · started May 10, 2021ClinicalTrials.gov NCT05368038 · fetched Nov 12, 2026
- A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2PHASE3 · TERMINATED · started Jun 29, 2020ClinicalTrials.gov NCT04221451 · fetched Nov 12, 2026
- Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BPHASE2_PHASE3 · COMPLETED · started Jan 28, 2020ClinicalTrials.gov NCT03974113 · fetched Nov 12, 2026
- Developing a Management Approach for Patients With "Late-Onset" Pompe DiseaseACTIVE_NOT_RECRUITING · started Mar 25, 2019ClinicalTrials.gov NCT03694561 · fetched Nov 12, 2026
- Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IXPHASE3 · COMPLETED · started Jan 9, 2019ClinicalTrials.gov NCT03754790 · fetched Nov 12, 2026
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsPHASE2 · ENROLLING_BY_INVITATION · started Sep 13, 2018ClinicalTrials.gov NCT03292861 · fetched Nov 12, 2026
- A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase AlfaPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 12, 2017ClinicalTrials.gov NCT03019406 · fetched Nov 12, 2026
- Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 4, 2017ClinicalTrials.gov NCT02843035 · fetched Nov 12, 2026
- LEMTRADA Pregnancy Registry in Multiple SclerosisCOMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT03774914 · fetched Nov 12, 2026
- Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe DiseaseRECRUITING · started Sep 1, 2009ClinicalTrials.gov NCT01665326 · fetched Nov 12, 2026
- Pompe Pregnancy Sub-RegistryRECRUITING · started Jun 18, 2007ClinicalTrials.gov NCT00567073 · fetched Nov 12, 2026
- Pompe Disease Registry ProtocolRECRUITING · started Sep 15, 2004ClinicalTrials.gov NCT00231400 · fetched Nov 12, 2026
- Mucopolysaccharidosis I (MPS I) RegistryCOMPLETED · started Nov 20, 2003ClinicalTrials.gov NCT00144794 · fetched Nov 12, 2026
- A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell CarcinomaPHASE1_PHASE2 · COMPLETED · started Dec 1, 2002ClinicalTrials.gov NCT00625755 · fetched Nov 12, 2026
- Fabry Disease Registry & Pregnancy Sub-registryRECRUITING · started Jul 31, 2001ClinicalTrials.gov NCT00196742 · fetched Nov 12, 2026
- The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance MelanomaPHASE1_PHASE2 · COMPLETED · started Jul 1, 2000ClinicalTrials.gov NCT00626860 · fetched Nov 12, 2026
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registryRECRUITING · started Apr 1, 1991ClinicalTrials.gov NCT00358943 · fetched Nov 12, 2026